Eosinophil Induced Remodelling in Asthma
NCT02648074 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2020-02-26
Summary
Asthma is a chronic, inflammatory disease of the lung characterized by intermittent airway obstruction, airway hyperresponsiveness, presence of activated inflammatory cells, inflammatory mediators, and airway structural changes. Airway smooth muscle (ASM) cells actively participate in the remodelling and inflammatory processes through proliferation, release of proinflammatory cytokines, chemokines, and extracellular matrix (ECM) proteins. Eosinophils as essential inflammatory cells may be of importance in ASM remodelling. It is known that eosinophil induces ASM cells proliferation via the secretion of cysteinyl leukotrienes in asthmatics. However there is a possible direct eosinophil-ASM cells functional interaction by adhesion processes. It has been shown that integrins modulate ASM proliferation and contractile protein expression demonstrating allergen-induced ASM remodelling in an animal model of allergic asthma.
Wingless/integrase-1 (WNT) signaling regulates not only a wide range of developmental processes, but its aberrant activation can lead to disease. Recently, it was confirmed that genes polymorphisms in the WNT signaling pathway are associated with impaired lung function in childhood asthma. It was also found for the first time a relevant role of noncanonical WNT signaling in TGFβ-induced ECM expression by ASM cells and identified WNT-5A is the most abundant WNT ligand with increased expression in asthmatics. It demonstrates that WNT-5A could contribute to remodelling of the airways. Unfortunately, the effect of eosinophil on WNT secretion by ASM cells at present is unknown.
Despite the widely acknowledged significance of eosinophils in asthma pathogenesis, the mechanism of eosinophil induced ASM remodelling is unsolved.
Conditions
- Allergic Asthma
- Airway Remodelling
Interventions
- PROCEDURE
-
Bronchial challenge with allergen
Bronchial challenge is performed with D. pteronyssinus allergen.
- OTHER
-
Co-culture formation
Eosinophil and linear bronchial smooth muscle cell co-culture formation. Airway smooth muscle cell proliferation, eosinophil adhesion to the bronchial smooth muscle cells, the role of eosinophil integrins in the airway remodelling process is assessed in individual formed co-culture
Sponsors & Collaborators
-
Research Council of Lithuania
collaborator OTHER -
University of Groningen
collaborator OTHER -
Lithuanian University of Health Sciences
lead OTHER
Principal Investigators
-
Kestutis Malakauskas, Prof., dr. · Lithuanian University of Health Sciences, Pulmonology and Immunology Department
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-03-31
- Primary Completion
- 2016-10-31
- Completion
- 2017-01-31
Countries
- Lithuania
Study Locations
More Related Trials
-
Exercise Rehabilitation for Children With Asthma
NCT06272604 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
How Airway Remodeling and Hyperresponsiveness Contribute to Airflow Obstruction in Asthma
NCT00186693 ·Status: WITHDRAWN
-
Progression of Airway Obstruction in Childhood Asthma
NCT00873873 ·Status: COMPLETED
-
Airway Remodeling During Mepolizumab Treatment
NCT03797404 ·Status: COMPLETED
-
Efficacy and Safety Study of Reslizumab to Treat Poorly Controlled Asthma
NCT00587288 ·Status: COMPLETED ·Phase: PHASE2
-
Airway Inflammation and Bronchial Hyperresponsiveness in Rhinitic Children With or Without Asthma
NCT02360072 ·Status: COMPLETED
-
Effect of Aerobic Training in Moderate or Severe Asthmatic Patients
NCT02033122 ·Status: UNKNOWN ·Phase: PHASE3
-
Two Investigational Drugs in the Prevention of Airway Constriction Brought on by Exercise in Participants With Asthma (0476-911)
NCT00127166 ·Status: COMPLETED ·Phase: PHASE3
-
Response of FeNO, Small Airway Dysfunction and Lung Heterogeneity to 2-week Montelukast Treatment in Asthmatic Children.
NCT01581710 ·Status: COMPLETED ·Phase: NA
-
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
NCT01225913 ·Status: RECRUITING ·Phase: PHASE4
-
Follow-up of Mild Eosinophilic Asthma
NCT04650503 ·Status: UNKNOWN
-
Individualizing Treatment for Asthma in Primary Care
NCT06272370 ·Status: COMPLETED ·Phase: PHASE4
-
Adapting Body Reprogramming for Severe Asthma: a Feasibility Study
NCT04980755 ·Status: COMPLETED ·Phase: NA
-
Asthma Control, Quality of Life and Emotional Feelings in a Real Life Setting
NCT02640742 ·Status: COMPLETED
-
SAMBA Trial: Towards a Paradigm Shift in Severe Asthma Management: Deep Analysis of the Effect of suBmaximal Aerobic Training
NCT04395937 ·Status: RECRUITING ·Phase: NA
-
Outcomes From an Asthma Disease Management Program
NCT00137722 ·Status: COMPLETED
-
Aerobic and Respiratory Exercises on Asthma
NCT04412720 ·Status: COMPLETED ·Phase: NA
-
Effect of Benralizumab on Airway Remodeling in Asthma
NCT04365205 ·Status: RECRUITING
-
Change of Airway Hyperresponsiveness to Mannitol and Methacholine in Patients With Asthma
NCT01725360 ·Status: COMPLETED ·Phase: PHASE4
-
Early Antiinflammatory Treatment of Asthma
NCT00567463 ·Status: TERMINATED ·Phase: NA
-
Airway Temperature
NCT02401074 ·Status: WITHDRAWN ·Phase: PHASE1
-
Functional Activity of Airway Eosinophils in Allergic Disease
NCT01026532 ·Status: COMPLETED
-
Effect of Montelukast on the Airway Remodeling
NCT00699062 ·Status: COMPLETED ·Phase: PHASE4
-
Nasal Inflammation Following Endotoxin Challenge in Patients With Asthma
NCT06270576 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Microglia Activation in Asthma
NCT04307667 ·Status: RECRUITING